| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |